AMPUTATIONS OF LOWER LIMBS [Autosaved] copy.pptx

prayashpaudel2 76 views 79 slides May 04, 2024
Slide 1
Slide 1 of 79
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51
Slide 52
52
Slide 53
53
Slide 54
54
Slide 55
55
Slide 56
56
Slide 57
57
Slide 58
58
Slide 59
59
Slide 60
60
Slide 61
61
Slide 62
62
Slide 63
63
Slide 64
64
Slide 65
65
Slide 66
66
Slide 67
67
Slide 68
68
Slide 69
69
Slide 70
70
Slide 71
71
Slide 72
72
Slide 73
73
Slide 74
74
Slide 75
75
Slide 76
76
Slide 77
77
Slide 78
78
Slide 79
79

About This Presentation

Types of amputations and brief description


Slide Content

AMPUTATIONS OF LOWER LIMBS Presented by: Dr. Prayash Paudel (JR2) Department of Orthopedics KMCTH Sinamangal , Kathmandu

Mangled extremity severity score Points Skeletal /soft tissue groups Shock groups Ischemia groups Age groups Normotensive None <30 years 1 Low energy Transient hypotensive Mild 30-50 years 2 Medium energy Prolonged hypotension Moderate >50 years 3 High energy Advanced 4 Very high energy Points multiplied by 2 if ischemia time exceeds > 6 hours Score: 3-6 = viable 7-12 = requires amputation

Predictive salvage index Points Level of arterial injury Degree of bone injury Degree of muscle injury Interval between injury till arrival to OT < 6 hours 1 Suprapopliteal Mild Mild 2 Popliteal Moderate Moderate 6-12 hours 3 Infrapopliteal severe severe 4 > 12 hours

Others Limb salvage index Ganga scoring system

Indications Trauma Peripheral vascular diseases Neuropathy Infection Tumour

Indicators of adequate perfusion Ankle brachial index > 0.5 Transcutaneous oxygen perfusion pressure > 40mm Hg

Prerequisite for adequate healing Serum albumin > 3.5 g/dl Total lymphocyte count > 1500/ml

Phantom limb pain Point prevalence : 6.7%–88.1% Period prevalence 1 to 3-month : 49%-93.5%, Lifetime prevalence : 76%–87%. Telescoping - 24.6% within a 1-month prevalence period Phantom limb sensation Point prevalence: 32.4%- 90%, Period prevalence 1 month - 65% 3 months - 56.9% and Lifetime prevalence - 87%.

Mean of reamputation 20.14% at 1 year 29.63% at 3 years 45.72% at 5 years

Ray amputation

Hallux valgus deformity

Smith fixation

No need of flap while removing sesamoid

TERMINAL SYME AMPUTATION

Cont …

Custom shoe

Transmetatarsal amputation Cascading fashion

Cont …

Cont …

Chopart amputation

Cont …

Cont …

Postoperative care Sutures: 4-6 weeks Splints: 4-6 weeks Prevent equinus contracture Ankle foot orthosis

Chopart amputation

Equinus deformity

How to prevent equinus deformity Burgess and lieberman et al. Recommendation Division of the Achilles tendon and Placement in a rigid dressing in slight dorsiflexion for 6 weeks

Treatment Tibiotalocalcaneal arthrodesis

Pirogoff amputation

Cont …

Requirements for a successful midfoot amputation Palpable posterior tibial pulse Distal infections not extending proximally to the midfoot level, Tcpo2 > 37 mm Hg, Hemoglobin level > 10 g/dl, and Serum albumin level > 30 g/L.

Syme amputation

Cont …

Cont …

Cont …

Cont …

Postoperative care

Wagner- Syme amputation First stage Ankle disarticulation Preserving the tibial articular cartilage and the malleoli, and Syme -type closure over a suction-irrigation system. Second stage procedure After 6 weeks Stump need should heal Performed to remove the malleoli and narrow the stump for good prosthetic fitting.

Wagner- Syme second stage

Postoperative care Walking cast after 10-12 days Change cast every 2 weeks. Prosthesis about 8 weeks after surgery.

Boyd amputation

Cont …

Postoperative care Sutures removed after 2 weeks Steinmann pin removed after 4 weeks. Weight bearing on the stump is prohibited until 8 weeks. A walking cast applied until arthrodesis is complete

Energy expenditure in locomotion Transtibial amputee: 40-50% Transfemoral amputee: 90-100%

Transtibial amputation

Non ischemic limbs Ideal length : 12.5- 17.5 cm For each 30 cm body height – add 2.5 cm Most satisfactory level -15 cm distal to the medial tibial articular surface. A stump < 12.5 cm long is less efficient. In a short stump of < 8.8 cm, entire fibula together with some of the muscle bulk be removed

Transtibial amputation

Cont …

Modified Ertl amputation

Cont …

Cont …

Ischemic limbs Recommendation: Tension myodesis contraindicated Osteomyoplasty contraindicated Use long posterior myocutaneous flap Short or absent anterior flap

Cont … Amputations performed are at a higher level than amputations in nonischemic limbs 10 -12.5 cm distal to the joint line Use of tourniquet doesnot increase risk of vascular and wound related complications.

Burgess amputation

Cont …

Rehabilitation Nonischemic amputation Nonweight bearing with bilateral upper extremity support Within 3 to 4 weeks, the rigid dressing can be changed to a removable temporary prosthesis Ischemic amputation Well padded cast to avoid constriction of limb proximally

Disarticulation of knee Advantages Preservation of the large end-bearing surfaces of the distal femur Creation of a long lever arm controlled by strong muscles, and Stability of the prosthesis.

Knee disarticulation

Cont ….

Cont …

Mazet and hennessy disarticulation of knee

Transfemoral amputations

Transfemoral (above-knee) amputation of nonischemic limbs

Cont …

Myodesis

Hip disarticulation 0.5% of lower extremity amputations. For treatment of bone or soft-tissue sarcomas

Boyd hip disarticulation

Cont …

Modified hemipelvectomy

Standard hemipelvectomy

Cont …

Cont …

Postamputation pain management

Others Duloxetine ( cymbalta ) FDA-approved For both depression and neuropathic pain which are associated with diabetes. 60 mg/day Avoided in patients with hepatic impairment, severe renal disease, or serious or unstable medical conditions. In patients with an inadequate therapeutic response to duloxetine 60 mg/day, addition of pregabalin or gabapentin is recommended Nausea, dizziness, somnolence, fatigue, sweating, dry mouth, constipation, and diarrhea

Polycentric hip joints

Microprocessors knees

Thank you